Low-dose aspirin at ≤16�weeks of gestation for preventing preeclampsia and its maternal and neonatal adverse outcomes: A systematic review and meta-analysis
| Autor: | Yuechong Cui, Fei Zheng, Bin Zhu |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Gestational hypertension
low-dose aspirin Cancer Research medicine.medical_specialty Placebo Preeclampsia preeclampsia 03 medical and health sciences 0302 clinical medicine Immunology and Microbiology (miscellaneous) Medicine 030212 general & internal medicine Adverse effect reproductive and urinary physiology Aspirin 030219 obstetrics & reproductive medicine business.industry Obstetrics Articles General Medicine medicine.disease female genital diseases and pregnancy complications meta-analysis Meta-analysis Relative risk Gestation business medicine.drug |
| Zdroj: | Experimental and Therapeutic Medicine |
| ISSN: | 1792-1015 1792-0981 |
| DOI: | 10.3892/etm.2018.5972 |
| Popis: | The aim of the present meta-analysis study was to evaluate the efficacy of low-dose aspirin, commenced at ≤16 weeks of gestation, in preventing preterm and term preeclampsia, as well as associated maternal and neonatal adverse events in women at risk of preeclampsia. The Embase, PubMed, Cochrane Central Register of Controlled Trials and the Web of Science databases were searched for relevant random controlled trials (RCTs) published between January 1979 and October 2017. After quality assessment and data extraction, a meta-analysis was performed using RevMan 5.3 software. Outcomes of interest were preeclampsia with subgroups of preterm preeclampsia (delivery at |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|